Yuliya A. Dolgusheva

Yuliya A. Dolgusheva

Auto-generated profile, based on publicly available information

Yuliya A. Dolgusheva

Chazov National Medical Research Center of Cardiology

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2023 in Almanac of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ASAleksandra M. Shchinova
Aleksandra M. Shchinova
APAlexandra Potekhina
Alexandra Potekhina
YDYuliya A. Dolgusheva
Yuliya A. Dolgusheva
YEYuliya E. Efremova
Yuliya E. Efremova
AOAnna K. Osokina
Anna K. Osokina
ПВПотехина Александра Викторовна
Потехина Александра Викторовна
Background: The extent of myocardial damage largely determines both in-hospital and long-term mortality in patients with acute coronary syndrome. According to the literature, the in-hospital and long-term mortality rates in patients with unstable angina (UA) are lower than those in the patients with myocardial infarction (MI). Aim: To evaluate the in-hospital and long-term mortality rates and their predictors in patients undergoing in-patient treatment for acute coronary syndrome (MI and UA) in the regional cardiovascular center with the service territory of 1 million persons. Materials and methods: This retrospective registry study enrolled 1130 patients (715 [63.3%] men, 415 [36.7%] women) who were treated for UA and MI in the regional cardiovascular center in 2019. Based on the discharge diagnosis, the patients were divided into two groups: patients with MI (n = 766) and those with an UA episode (n = 364). The in-hospital and delayed mortality rates, as well as their predictors, were analyzed in both groups. The mean duration of the follow-up was 17.8 3.6 months. Results: The in-hospital mortality in patients with confirmed MI was 11.1% (85 patients) versus 0.27% (1 patient) in the UA patients (p 0.001). The independent predictors of in-hospital mortality in MI patients were a decreased left ventricular ejection fraction (LV EF) (odds ratio (OR) 0.9021, 95% confidence interval (CI) 0.82090.9914, p = 0.0324), chronic kidney disease C3a and above (OR 9.3205, 95% CI 2.670632.5283, p = 0.0005), and the extension of coronary involvement at coronary angiography (OR 1.3526, 95% CI 1.06670.0127, p = 0.0127). The long-term mortality in MI patients was 10.4% (72 patients) with no significant difference from that in UA patients (9.9%, 36 patients, p = 0.76). The independent predictors of long-term mortality after MI were older age (OR 1.12, 95% CI 1.011.22, p = 0.0052), chronic kidney disease C3a and above (OR 2.3375, 95% CI 1.13924.7963, p = 0.0206), decreased EF (OR 0.8895, 95% CI 0.730.99, p = 0.0364), atrial fibrillation on admission (OR 3.1462, 95% CI 1.35107.3268, p = 0.0079), and diabetes mellitus (OR 2.3163, 95% CI 1.25524.2744, p = 0.0072). In the UA patients, the predictors of the long-term mortality were a decrease in LV EF (OR 0.9139, 95% CI 0.86830.9619, p = 0.0006) and in blood hemoglobin level (OR 0.9729, 95% CI 0.95440.9917, p = 0.0050). Conclusion: The in-hospital mortality in UA patients is lower than that in MI patients, with comparable long-term mortality. This indicates the need of active follow-up of the patients with past UA, irrespective of the endovascular assessment and intervention.

19 October 2022 in National Health Care (Russia)
Verified
Journal Article
Open access
PDF file
SBSergey Boytsov
Sergey Boytsov
YEYu. E. Efremova
Yu. E. Efremova
NLN. V. Lazareva
N. V. Lazareva
YDYu. A. Dolgusheva
Yu. A. Dolgusheva
ESE. V. Sorokin
E. V. Sorokin
The article presents the modern strategy of an outpatient cardiovascular care improvement. The modernization of primary health care in outpatient network is based on primary and secondary prevention of cardiovascular diseases including an improvement of outpatient observation, development of an outpatient high-risk offices network, advancement of telemedical consulting, increase of preferential medication provision effectiveness, increase of quality management patients with chronic heart failure and development of vertically integrated medical information system. Improvement of cardiovascular outpatient care will reduce cardiovascular mortality in the whole population.

11 June 2024 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
PDF file
MUMadina D. Utsumueva
Madina D. Utsumueva
NMNikolay Yu. Mironov
Nikolay Yu. Mironov
SGSergey P. Golitsyn
Sergey P. Golitsyn
YDYulia A. Dolgusheva
Yulia A. Dolgusheva
VBValery V. Beregovykh
Valery V. Beregovykh
ШЛШимановский Николай Л.
Шимановский Николай Л.
Atrial fibrillation (AFib) and chronic heart failure (CHF) are frequently encountered cardiovascular conditions that share common causes and tend to coexist in some patients. Such coexistence represents a major issue due to augmentation of symptoms severity, rapid deterioration, and poor prognosis. Management of patients with AFib and CHF is challenging due to limitations in pharmacotherapy and decreased efficacy of cardiac interventions. In this review we focus on crucial pathogenic components of AFib and CHF coexistence, key treatment approaches and discuss potential for implementation of artificial intelligence.

5 December 2023 in Kardiologiia
Verified
Journal Article
Open access
PDF file
KBK. S. Benimetskaya
K. S. Benimetskaya
SPS. I. Provatorov
S. I. Provatorov
Marat EzhovMarat Ezhov
Marat Ezhov
YKY. S. Krivosheev
Y. S. Krivosheev
AGA. D. Gavrilko
A. D. Gavrilko
Denis LosikDenis Losik
Denis Losik
Aim To evaluate prescription of lipid-lowering and antithrombotic therapy in clinical practice and to compare differences in recommendations using the clinical decision support service (CDSS). Material and methods Electronic medical records (EMR) of 300 patients from the Chazov National Medical Research Center of Cardiology, as well as from medical organizations controlled by the Department of Health of the Lipetsk Region and the Ministry of Health of the Voronezh Region, were analyzed for the period of August - December 2022, during the pilot implementation of CDSS. Retrospective information about the prescription of lipid-lowering and antithrombotic therapy from the EMR was compared with the CDSS guidelines under the expert supervision based on digitized clinical and laboratory profiles of patients. The study primary endpoint was a change in the initially prescribed lipid-lowering and / or antithrombotic therapy as per CDSS guidelines. Results Overall 292 patients were included in the final analysis; 46 (15.7 %) were from the primary prevention group and 246 (84.3 %) from the secondary prevention group. In group 1, the lipid-lowering therapy recommended by the CDSS differed by 50 % (p<0.001) from the baseline therapy recorded in the EMR. In the secondary prevention group, 78.9 % (p<0.001) differences were found in the lipid-lowering therapy recommended in the CDSS guidelines compared to the prescriptions in the EMR. In 76.8 % (p<0.001) of patients, antithrombotic therapy was significantly different from the baseline therapy in the EMR. Conclusion The use of CDSS may improve the practice of choosing lipid-lowering and antithrombotic therapy for prevention of cardiovascular complications.

9 February 2022 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ASA. M. Shchinova
A. M. Shchinova
AOA. K. Osokina
A. K. Osokina
APAlexandra Potekhina
Alexandra Potekhina
ISI. I. Shestova
I. I. Shestova
AFAnastasiia Yu. Filatova
Anastasiia Yu. Filatova
SPS. I. Provatorov
S. I. Provatorov
Aim. To compare the prevalence of coronary atherosclerosis in patients after coronary stenting (CS) receiving outpatient and remote cardiology follow-up during a one-year study.Material and methods. We enrolled 279 patients aged 61,5±9,5 years with class ≥II stable angina or silent ischemia after CS. Three groups were formed: group 1 (n=96) — outpatient visits before CS, 1, 3, 6 and 12 months after CS. Group 2 (n=95) — remote monitoring: patients were followed up by a primary care physician with the involvement of a cardiologist via remote communication (e-mail, telephone, Skype) 1, 3, 6 and 12 months after CS. Group 3 (n=88) were followed up by a primary care physician and contacted with the study coordinator before and 12 months after CS. After 12 months, all patients underwent stress-induced myocardial ischemia testing. In case of a positive or uncertain test result, coronary angiography (CA) was performed.Results. Stress-induced myocardial ischemia 12 months after CS was verified in 58 patients (21%): 19 patients (19,8%) — group 1; 9 patients (9,5%) — group 2; 30 patients (34,1%) — group 3 (p<0,05). Repeat CA was performed in 96 patients (34,4% of the total number of patients). Restenosis was detected in 8 (2,9%) patients, coronary atherosclerosis progression — in 38 (13,6%), combination of restenosis and atherosclerosis progression — in 4 (1,4%) patients. Coronary atherosclerosis progression was significantly more frequent in group 3: 10,4%, 9,5% and 21,6% in groups 1, 2 and 3, respectively (p<0,05). The incidence of stent restenosis was comparable: 2,1%, 3,2% and 3,5% in groups 1, 2, and 3, respectively.Conclusion. Coronary atherosclerosis progression was the main reason for repeated revascularizations 12 months after the CS. Outpatient and remote cardiology follow-up is associated with a lower incidence of coronary atherosclerosis progression and repeated CA during 12-month follow-up after CS.

20 February 2025 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
IAIrina V. Atyunina
Irina V. Atyunina
ESEvgeny V. Sorokin
Evgeny V. Sorokin
YDYuliya A. Dolgusheva
Yuliya A. Dolgusheva
Aim. Тo evaluate the quality of dispensary observation (DO) and treatment after myocardial infarction in accordance with the current DO-algoritm and clinical guidelines (CG). Materials and methods. A questionnaire collection of data of the quality of DO and CG compliance was conducted in 28 regions of the Russian Federation (1241 questionnaires). The quality of DO was assessed according to a number of criteria, including the timing of establishing DO and issuing prescriptions for drugs, the specialty of the doctor performing DO, the frequency of DO-visits and adherence to the diagnostic algorithm, compliance with drug prescriptions current CG. Results. Timely DO, cardiologist's follow up of patients discharged from the hospitall did not take place in all regions. The diagnostic algorithms of DO were generally followed, however, the drug therapy did not fully comply to CG, especially in beta-blockers and drugs that affect the renin-angiotensin system. Conclusion. There is a need for further improvement of the DO of patients with myocardial infarction. The introduction, modernization of additional mechanisms that ensure the continuity and efficiency of the diagnostic, treatment process, and the optimization of drug treatment will improve the quality of outpatient cardiac care and DO.